{"id":879917,"date":"2025-08-28T07:06:15","date_gmt":"2025-08-28T11:06:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/"},"modified":"2025-08-28T07:06:15","modified_gmt":"2025-08-28T11:06:15","slug":"cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/","title":{"rendered":"Cartesian Therapeutics to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">FREDERICK, Md., Aug.  28, 2025  (GLOBE NEWSWIRE) &#8212; Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the \u201cCompany\u201d), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that its management expects to participate in the following investor conferences in September:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">A fireside chat at the Cantor Global Healthcare Conference 2025 at 11:30 a.m. ET on Thursday, September 4, 2025<\/li>\n<li style=\"text-align:justify\">A fireside chat at Morgan Stanley\u2019s 23<sup>rd<\/sup> Annual Healthcare Conference at 4:05 p.m. ET on Tuesday, September 9, 2025<\/li>\n<li style=\"text-align:justify\">A presentation at the H.C. Wainwright 27<sup>th<\/sup> Annual Global Investment Conference at 8:30 a.m. ET on Wednesday, September 10, 2025<\/li>\n<\/ul>\n<p align=\"justify\">Live webcasts of the fireside chats and presentation are expected to be accessible in the Events section of the Company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VZj2ev4Jh7IaXk6O_WseLMoI19gPN9y9wHMpA4-3SdcaaH9uYDJ3d4CQfVRVseW_jFOZsb__j-EWg8qSQ9eDpFYponcRK7IXDrlHMWdA4ctWxqH2otVz-iWN4WT0f1YMjTs9RvicOQz4aRL7JJDz1T0B_ruYTsvN3w3O1qczuJWf_ifJNH2M6pwH16Oo4yBPCVBSC7dbbO8HqvhObPNAMCl8TzoSmONB_sHXkM38DchmWXLBgvytT3auCkTpOfZjiyxZ2YPDmCsDroAf_pUBnLSO6msY5OjYTlfBMMHDhhMS4Zksu9MxIGUBkQH6EF12\" rel=\"nofollow\" target=\"_blank\">www.cartesiantherapeutics.com<\/a>, where an archived replay of the events will also be available for a limited time.<\/p>\n<p align=\"justify\">\n        <strong>About Cartesian Therapeutics<\/strong>\n      <\/p>\n<p align=\"justify\">Cartesian Therapeutics is a clinical-stage company pioneering cell therapy for the treatment of autoimmune diseases. The Company\u2019s lead asset, Descartes-08, is a CAR-T in Phase 3 clinical development for patients with generalized myasthenia gravis and Phase 2 development for systemic lupus erythematosus, with a Phase 2 basket trial planned in additional autoimmune indications. The Company\u2019s clinical-stage pipeline also includes Descartes-15, a next-generation, autologous anti-BCMA CAR-T currently being evaluated in a Phase 1 trial in patients with multiple myeloma. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VZj2ev4Jh7IaXk6O_WseLMoI19gPN9y9wHMpA4-3SdfOlZZtbfryIwQvgh_Upn4gUDGVOUHC2YLugxJVOODF_vk4dlig5tyZKOG_M1JnjX0HiNPVzq0K0_qnX9JnBRby\" rel=\"nofollow\" target=\"_blank\">www.cartesiantherapeutics.com<\/a> or follow the Company on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QwZ5eU-9CcYiTavOGkGEfUJ-iM8sEruew61qJW8nL0PMUccLlMihhJqThuAgLkFG78QpBJVrmkgqJ70YndhkAlqEfvx0cZ9dRSdeTmHFLUO27bu0mJ3oPHWVRJQm0r7S\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1DgdIEVeANQvLiJ4k3CBM6gMbQpGRXEEGqnbTmo4TqvelhGGXeiJQmRLNRS5IfRpLOpXRjAvrdaEXeseco7etg==\" rel=\"nofollow\" target=\"_blank\">X<\/a>, formerly known as Twitter.<\/p>\n<p align=\"justify\">\n        <strong>Investor Contact<\/strong>\n      <\/p>\n<p align=\"justify\">Megan LeDuc<br \/>Associate Director, Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=t3-wmSTn7VYjvuahpqSXS8d88DSZBaGa9CAWXcP_iMpzapcKlulM8KnA0Smld-idXTzbCbLaksnaeq_C6L9ieGsspG2SesOcee-iY9M65_hJHezLe5nRAyA0n_PpIdIL\" rel=\"nofollow\" target=\"_blank\">megan.leduc@cartesiantx.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Media Contact<\/strong>\n      <\/p>\n<p align=\"justify\">David Rosen<br \/>Argot Partners<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZEBADENDS8jcVr5QC0xbO4gL3WiKOePFD1mB1XcWSd85XQB8EF6kf0fn_w0WCTWGuqsZmL8XCFwQKUZz7W6fGLDCjY4H5btzPT3DTXoity5b0WFqOkSN1hMuhe_SgRQu\" rel=\"nofollow\" target=\"_blank\">david.rosen@argotpartners.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxOTIyNyM3MTE4NTg4IzIwNTAxMjk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/M2IwNjAyZmUtMWVlNS00YmZiLWFiOWMtZWUzZWUyYjA1NzAzLTEwNjE3MDAtMjAyNS0wOC0yOC1lbg==\/tiny\/Cartesian-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>FREDERICK, Md., Aug. 28, 2025 (GLOBE NEWSWIRE) &#8212; Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the \u201cCompany\u201d), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that its management expects to participate in the following investor conferences in September: A fireside chat at the Cantor Global Healthcare Conference 2025 at 11:30 a.m. ET on Thursday, September 4, 2025 A fireside chat at Morgan Stanley\u2019s 23rd Annual Healthcare Conference at 4:05 p.m. ET on Tuesday, September 9, 2025 A presentation at the H.C. Wainwright 27th Annual Global Investment Conference at 8:30 a.m. ET on Wednesday, September 10, 2025 Live webcasts of the fireside chats and presentation are expected to be accessible in the Events section of the Company\u2019s website at\u00a0www.cartesiantherapeutics.com, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cartesian Therapeutics to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-879917","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cartesian Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cartesian Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"FREDERICK, Md., Aug. 28, 2025 (GLOBE NEWSWIRE) &#8212; Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the \u201cCompany\u201d), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that its management expects to participate in the following investor conferences in September: A fireside chat at the Cantor Global Healthcare Conference 2025 at 11:30 a.m. ET on Thursday, September 4, 2025 A fireside chat at Morgan Stanley\u2019s 23rd Annual Healthcare Conference at 4:05 p.m. ET on Tuesday, September 9, 2025 A presentation at the H.C. Wainwright 27th Annual Global Investment Conference at 8:30 a.m. ET on Wednesday, September 10, 2025 Live webcasts of the fireside chats and presentation are expected to be accessible in the Events section of the Company\u2019s website at\u00a0www.cartesiantherapeutics.com, &hellip; Continue reading &quot;Cartesian Therapeutics to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T11:06:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxOTIyNyM3MTE4NTg4IzIwNTAxMjk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cartesian Therapeutics to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2025-08-28T11:06:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/\"},\"wordCount\":259,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxOTIyNyM3MTE4NTg4IzIwNTAxMjk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/\",\"name\":\"Cartesian Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxOTIyNyM3MTE4NTg4IzIwNTAxMjk=\",\"datePublished\":\"2025-08-28T11:06:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxOTIyNyM3MTE4NTg4IzIwNTAxMjk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxOTIyNyM3MTE4NTg4IzIwNTAxMjk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cartesian Therapeutics to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cartesian Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/","og_locale":"en_US","og_type":"article","og_title":"Cartesian Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"FREDERICK, Md., Aug. 28, 2025 (GLOBE NEWSWIRE) &#8212; Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the \u201cCompany\u201d), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that its management expects to participate in the following investor conferences in September: A fireside chat at the Cantor Global Healthcare Conference 2025 at 11:30 a.m. ET on Thursday, September 4, 2025 A fireside chat at Morgan Stanley\u2019s 23rd Annual Healthcare Conference at 4:05 p.m. ET on Tuesday, September 9, 2025 A presentation at the H.C. Wainwright 27th Annual Global Investment Conference at 8:30 a.m. ET on Wednesday, September 10, 2025 Live webcasts of the fireside chats and presentation are expected to be accessible in the Events section of the Company\u2019s website at\u00a0www.cartesiantherapeutics.com, &hellip; Continue reading \"Cartesian Therapeutics to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-28T11:06:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxOTIyNyM3MTE4NTg4IzIwNTAxMjk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cartesian Therapeutics to Participate in Upcoming Investor Conferences","datePublished":"2025-08-28T11:06:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/"},"wordCount":259,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxOTIyNyM3MTE4NTg4IzIwNTAxMjk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/","name":"Cartesian Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxOTIyNyM3MTE4NTg4IzIwNTAxMjk=","datePublished":"2025-08-28T11:06:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxOTIyNyM3MTE4NTg4IzIwNTAxMjk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxOTIyNyM3MTE4NTg4IzIwNTAxMjk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cartesian Therapeutics to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/879917","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=879917"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/879917\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=879917"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=879917"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=879917"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}